Compliance Tips For Running Clinical Trials During COVID-19

May 20, 2020

By: Jill E. Anderson, Linda A. Malek, and Nora Lawrence Schmitt

Law360

Navigating the path forward to conduct clinical research in the midst of the COVID-19 pandemic has introduced unique challenges for sponsors and research institutions alike.

Industry sponsors and institutions are facing unprecedented issues resulting from the COVID-19 outbreak, such as clinical trial site closures, travel restrictions, limitations on the availability of investigational product and threats to the health and well-being of research personnel and study participants.

Click here to read the full article.

PDF File View as PDF